Table 5 Characteristics of the study patients at baseline with two or more treatment contacts in the observation period included in an analysis of variance
Total | Higher continuity of care | Lower continuity of care | p -value | |
|---|---|---|---|---|
Patients, n | 162 | 78 | 84 | |
Age in years, mean (SDa) | 46.8 (13.7) | 46.0 (13.4) | 47.6 (14.1) | 0.465 |
Sex, n (%) | ||||
female | 86 (53.1) | 42 (53.8) | 44 (52.4) | 0.876 |
male | 76 (46.9) | 36 (46.2) | 40 (47.6) | |
Migration background, n (%) | ||||
yes | 57 (35.2) | 29 (37.2) | 28 (33.7) | 0.742 |
no | 104 (64.2) | 49 (62.8) | 55 (66.3) | |
Main treatment diagnosis, n (%) | ||||
Organic, including symptomatic, mental disorders (ICD-10 F0) | 1 (0.6) | 0 | 1 (1.2) | 0.155 |
mental and behavioral disorders due to psychoactive substance use (ICD-10 F1) | 42 (25.9) | 25 (32.1) | 17 (20.2) | |
general psychiatric disorders (ICD-10 F2-7) | 119 (74.5) | 53 (67.9) | 66 (78.6) | |
thereof: | ––– | ––– | ––– | ––– |
F2 schizophrenia, schizotypal and delusional disorders | 39 (32.8) | 18 (34.0) | 21 (31.8) | |
F3 mood (affective) disorders | 52 (43.7) | 22 (41.5) | 30 (45.5) | |
F4 neurotic, stress-related and somatoform disorders | 12 (10.1) | 7 (13.2) | 5 (7.6) | |
F6 disorders of adult personality and behavior | 16 (13.4) | 6 (11.3) | 10 (15.2) | |
Duration of psychiatric disease, n (%) | ||||
< 1 year | 32 (19.8) | 17 (22.4) | 15 (18.3) | 0.809 |
1–10 years | 59 (36.4) | 28 (36.8) | 31 (37.8) | |
> 10 years | 67 (41.4) | 31 (40.8) | 36 (43.9) | |
Hospital, n (%) | ||||
model hospital | 93 (57.4) | 68 (87.2) | 25 (29.8) | < 0.001 |
control hospital | 69 (42.6) | 10 (12.8) | 59 (70.2) | |